2019
DOI: 10.1056/nejmicm1815549
|View full text |Cite
|
Sign up to set email alerts
|

Mucosal Neuromas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…In the recently published German GPOH-MET registry study, the relatively late appearance of mucosal neuromas/neurofibromas (mean age 10.1 year) did not significantly precede symptoms of MTC [ 12 ]. However, this feature should be a trigger for further diagnostic work-up and can lead to MEN2B diagnosis [ 33 35 ]. The characteristic wide maxillary midline diastema is a non-specific feature as a midline diastema is a normal stage of dental development with a prevalence of 25–40% in children with a mixed dentition [ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…In the recently published German GPOH-MET registry study, the relatively late appearance of mucosal neuromas/neurofibromas (mean age 10.1 year) did not significantly precede symptoms of MTC [ 12 ]. However, this feature should be a trigger for further diagnostic work-up and can lead to MEN2B diagnosis [ 33 35 ]. The characteristic wide maxillary midline diastema is a non-specific feature as a midline diastema is a normal stage of dental development with a prevalence of 25–40% in children with a mixed dentition [ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…After the diagnosis of MEN 2B, the patients' immediate family members should be screened for MTC and PCC, and early genetic testing for RET proto-oncogene mutations is necessary to achieve the purpose of early discovery and early treatment (17,18). Therefore, MEN 2B can be diagnosed by the special face caused by MN, the clinical manifestations of MTC, PCC and radiography, biochemical examinations, and it can be diagnosed early by detecting mutations in RET proto-oncogene (19). Our patient showed no abnormalities in the skeletal structure, lip shape, sonographic examination of the thyroid, or in any of the endocrine examinations, and there were no tumors elsewhere in the oral cavity or the ocular region.…”
Section: Discussionmentioning
confidence: 99%
“…In 1975, Khairi et al [1] proposed that the condition of combined medullary thyroid carcinoma (MTC), pheochromocytomas and mucosal neuroma (MN) should be referred to as multiple endocrine neoplasia (MEN) type 3, also known as multiple endocrine neoplasia type 2B (MEN 2B) now. MEN 2B is an autosomal dominant syndrome associated with RET gene mutations and characterized by an aggressive form of MTC and bilateral pheochromocytomas (PCC) [2,3]. MN of MEN 2B is always observed on the mucosal surfaces of the lips, tongue, eyelids, and intestines of patients [4], but rarely occur without the other abnormality about MEN 2B.…”
Section: Introductionmentioning
confidence: 99%
“…Clinically, MN usually presents as a rm, slowly enlarging, small, circumscribed mass, which is painless in most cases [3,7,13,16], although it can frequently cause symptoms such as pain and paresthesia [5,6,9,10,15]. In the vast majority of cases, complete surgical excision is curative; however, recurrences have been reported in some cases [14,17].…”
Section: Introductionmentioning
confidence: 99%